The metformin treatment (only at the higher concentration) resulted in a decrease in the TNFα production to comparable levels in blood cultures derived from all NAFLD patients—regardless of the presence of obesity (P≤0.01) (Fig 2C). This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.